10q10k10q10k.net
CRISPR Therapeutics AG

CRISPR Therapeutics AGCRSPEarnings & Financial Report

Nasdaq · biotechnology industry

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. I...

Top Holders

Holder% OwnedSharesChangeAs of
ARK10.69%
9.1M
▼ -0.06pp2024-12-10
OF ABOVE PERSONS10.20%
8.2M
▲ +2.10pp2024-04-10
Nikko Asset Management Americas, Inc.4.24%
3.4M
—2024-02-12
Sumitomo Mitsui Trust Holdings, Inc.4.24%
3.4M
—2024-02-05

Insider Transactions

Net 90d: −$3.23M · buys $0 / sells $3.23M
Range:
Action:
Role:
InsiderRoleAction
2026-03-23Raju PrasadChief Financial OfficerSell (open market)
3.7K
$46.78$173.5K
2026-03-23Samarth KulkarniChief Executive OfficerSell (open market)
10.0K
$46.78$468.7K
2026-03-23KASINGER JAMES R.General Counsel and SecretarySell (open market)
3.2K
$46.78$148.9K
2026-03-20Raju PrasadChief Financial OfficerOption exercise
6.3K
——
2026-03-20Samarth KulkarniChief Executive OfficerOption exercise
19.7K
——
2026-03-20KASINGER JAMES R.General Counsel and SecretaryOption exercise
6.3K
——
2026-03-16Raju PrasadChief Financial OfficerSell (open market)
5.8K
$48.26$282.2K
2026-03-16Raju PrasadChief Financial OfficerSell (open market)
4.0K
$48.26$194.1K
2026-03-16Raju PrasadChief Financial OfficerGift
750
$0.00$0
2026-03-16Naimish PatelChief Medical OfficerSell (open market)
3.1K
$48.26$152.0K
1–10 of 25
Page 1 / 3